Snippet from the article:
The Web site of Allergan Inc.’s Latisse is misleading because it suggests the company’s eyelash thickener is more safe than proven, federal regulators said.
In a letter to Allergan dated Sept. 10, the Food and Drug Administration said the company’s Web site omits information about how people using Latisse are at risk for contracting bacterial keratitis, which can be blinding. The letter was posted on the FDA’s Web site Wednesday.
Read the full text at Wall Street Journal.
This problem shows the value of the FDA in protecting our interests. You would not want to go blind and without proper informed consent on drugs, you may not know what you are getting yourself into. Cheers to the FDA.